Defining lines of therapy in haematological malignancies: a proposed systematic and comprehensive framework from the EBMT Practice Harmonisation and Guidelines Committee - Takeaways - MDSpire

Defining lines of therapy in haematological malignancies: a proposed systematic and comprehensive framework from the EBMT Practice Harmonisation and Guidelines Committee

  • By

  • Alessandro Criscimanna

  • Jacques-Emanuel Galimard

  • Isabel Sánchez-Ortega

  • Patrick J. Hayden

  • Laurent Garderet

  • Anna Sureda

  • Fabio Ciceri

  • Donal P. McLornan

  • Krzysztof Kałwak

  • Antonio M. Risitano

  • Francesco Onida

  • Ibrahim Yakoub-Agha

  • Ali Bazarbachi

  • Annalisa Ruggeri

  • June 3, 2026

  • 0 min

Share

  • 1

    The EBMT Practice Harmonisation and Guidelines Committee developed a standardized framework for defining lines of therapy (LoT) in hematological malignancies.

  • 2

    A line of therapy is defined as a coherent therapeutic episode aimed at disease control, including phases like induction, consolidation, or maintenance.

  • 3

    Variability in LoT definitions across studies hinders research and clinical practice, necessitating a standardized approach for clarity and consistency.

  • 4

    Bridging therapies prior to cellular therapy are considered part of the same LoT as the definitive treatment, enhancing treatment continuity.

  • 5

    The framework aims to improve methodological rigor and support evidence-based decision-making in precision hematology.

Original Source(s)

Related Content